In 2022, Guo et al. found that knocking out the IκBαT291 site in glioblastoma multiforme (GBM) cells inhibited the high glucose-induced expression of PD-L1 and promoted CD8 + T cell activation and infiltration. The gene discussed is CD274; the disease is glioblastoma.